Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

NCT01774604 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

449

Enrollment

OTHER

Sponsor class

Stopped Futility

Conditions

Post-ERCP Acute Pancreatitis

Interventions

DRUG: Indomethacin
DRUG: Placebo

Sponsor

Dartmouth-Hitchcock Medical Center